Advertisement
Journal Home
Search for

Volume 37, Issue 6, Pages 435-441 (August 2009)


View previous. 5 of 27 View next.

Extended-spectrum β-lactamase-producing pathogens in a children's hospital: A 5-year experience

Anne J. Blaschke, MD, PhDaCorresponding Author Informationemail address, E. Kent Korgenski, MSb, Judy A. Daly, PhDbc, Bonnie LaFleur, PhDa, Andrew T. Pavia, MDa, Carrie L. Byington, MDa

published online 20 January 2009.

Background

Pediatric infection with bacteria producing extended-spectrum β-lactamases (ESBLs) has not been well described. We sought to determine the proportion of isolates producing ESBLs and the incidence of infection or colonization with these organisms in our tertiary care pediatric facility over 5 years. In addition, we sought to evaluate the characteristics of children affected.

Methods

We identified all Escherichia coli or Klebsiella spp cultured from children younger than 18 years of age at our facility between January 2003 and December 2007. Medical records were reviewed for affected children.

Results

Of 2697 E coli, K pneumoniae, and K oxytoca cultured, 26 ESBL producers were isolated from 16 children. Rates of ESBL production among cultured isolates significantly increased, from 0.53% in the first half of the study period to 1.4% in the second. Incidence of a primary ESBL infection also increased significantly, from 0.14/10,000 patient encounters to 0.31/10,000. The majority of children infected or colonized with ESBL-producing organisms were those with chronic medical conditions, frequent hospitalizations, or a history of recurrent infection. However, 4 affected children were less than 5 months old and evaluated in an outpatient setting.

Conclusion

Rates and incidence of ESBL infection increased over the study period. Whereas most patients belonged to traditional risk groups for antibiotic-resistant infection, infants in the ambulatory setting were also affected, an at-risk population not previously described.

a Department of Pediatrics, University of Utah, Salt Lake City, UT

b Primary Children's Medical Center Microbiology Laboratory, Salt Lake City, UT

c Department of Pathology, University of Utah, Salt Lake City, UT

Corresponding Author InformationAddress correspondence to Anne Blaschke, MD, PhD, Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, PO Box 581289, Salt Lake City, UT 84158.

 Supported by an NIH/NICHD Child Health Research Career Development Award (5K12HD001410-04 to A.J.B.) and the Primary Children's Medical Center Foundation.

 Conflicts of interest: None to report.

PII: S0196-6553(08)00804-3

doi:10.1016/j.ajic.2008.09.019


View previous. 5 of 27 View next.